While pharmaceutical companies plan to build their own siloed AI chatbots, physicians and patients are already adopting public tools like ChatGPT for clinical communication. This creates a risk of developing redundant solutions that ignore established user behavior.

The scale of AI adoption in healthcare is not a future projection but a current reality, with over 230 million people using ChatGPT for health and wellness queries every week. This massive, existing user base establishes it as one of the fastest-growing use cases and reframes the challenge from driving initial adoption to scaling impact and ensuring safety for a global audience.

The next evolution in personalized medicine will be interoperability between personal and clinical AIs. A patient's AI, rich with daily context, will interface with their doctor's AI, trained on clinical data, to create a shared understanding before the human consultation begins.

To overcome resistance, AI in healthcare must be positioned as a tool that enhances, not replaces, the physician. The system provides a data-driven playbook of treatment options, but the final, nuanced decision rightfully remains with the doctor, fostering trust and adoption.

The conversation around AI in healthcare often focuses on patient-facing chatbots. However, the more significant, unspoken trend is adoption by clinicians themselves. As of last year, two out of three American doctors were already using AI for administrative tasks, translation, and even as a 'wingman' for clinical diagnosis.

An effective AI strategy in healthcare is not limited to consumer-facing assistants. A critical focus is building tools to augment the clinicians themselves. An AI 'assistant' for doctors to surface information and guide decisions scales expertise and improves care quality from the inside out.

The widespread use of AI for health queries is set to change doctor visits. Patients will increasingly arrive with AI-generated analyses of their lab results and symptoms, turning appointments into a three-way consultation between the patient, the doctor, and the AI's findings, potentially improving diagnostic efficiency.

AI adoption in healthcare has accelerated by sidestepping slow enterprise sales cycles. Companies like Open Evidence offer free, consumer-like apps directly to doctors (prosumers). This bottom-up approach creates widespread use, forcing organizations to adopt the technology once a critical mass of their staff is already using it.

Unlike the top-down, regulated rollout of EHRs, the rapid uptake of AI in healthcare is an organic, bottom-up movement. It's driven by frontline workers like pharmacists who face critical staffing shortages and need tools to manage overwhelming workloads, pulling technology in out of necessity.